Group One Trading, L.P. Global Blood Therapeutics, Inc. Transaction History

Group One Trading, L.P.

$2.4 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$22.3 - $37.39 $215,328 - $361,037	-9,656 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$25.68 - $35.59 $247,966 - $343,657	9,656 New	9,656 $334,000
Q4 2021 Feb 11, 2022	SELL	$24.9 - $40.26 $422,926 - $683,816	-16,985 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$25.48 - $37.34 $432,777 - $634,219	16,985 New	16,985 $433,000
Q2 2021 Aug 10, 2021	SELL	$32.46 - $43.42 $2.06 Million - $2.76 Million	-63,552 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$38.94 - $50.85 $2.51 Million - $3.28 Million	-64,442 Reduced 50.35%	63,552 $2.59 Million
Q4 2020 Feb 10, 2021	BUY	$37.65 - $63.77 $3.81 Million - $6.45 Million	101,133 Added 376.5%	127,994 $5.54 Million
Q3 2020 Nov 12, 2020	BUY	$52.76 - $74.49 $653,168 - $922,186	12,380 Added 85.49%	26,861 $1.48 Million
Q2 2020 Aug 13, 2020	SELL	$48.73 - $81.82 $1.15 Million - $1.93 Million	-23,559 Reduced 61.93%	14,481 $914,000
Q1 2020 May 13, 2020	BUY	$41.72 - $87.2 $1.59 Million - $3.32 Million	38,040 New	38,040 $1.94 Million
Q4 2019 Feb 10, 2020	SELL	$45.7 - $81.86 $542,916 - $972,496	-11,880 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$45.35 - $57.91 $1.36 Million - $1.74 Million	-30,092 Reduced 71.7%	11,880 $576,000
Q2 2019 Aug 09, 2019	BUY	$52.6 - $63.29 $2.21 Million - $2.66 Million	41,972 New	41,972 $2.21 Million
Q1 2019 May 13, 2019	SELL	$39.99 - $53.48 $1.33 Million - $1.77 Million	-33,153 Closed	0 $0
Q4 2018 Feb 06, 2019	BUY	$31.54 - $46.67 $712,709 - $1.05 Million	22,597 Added 214.07%	33,153 $1.36 Million
Q3 2018 Nov 08, 2018	SELL	$38.0 - $51.1 $1.48 Million - $1.99 Million	-38,901 Reduced 78.66%	10,556 $401,000
Q2 2018 Aug 14, 2018	BUY	$38.7 - $50.15 $1.91 Million - $2.48 Million	49,457 New	49,457 $2.24 Million
Q1 2018 May 11, 2018	SELL	$39.6 - $65.9 $1.51 Million - $2.52 Million	-38,216 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$29.7 - $45.7 $1 Million - $1.54 Million	33,676 Added 741.76%	38,216 $1.5 Million
Q3 2017 Nov 15, 2017	SELL	$25.1 - $31.05 $31,023 - $38,377	-1,236 Reduced 21.4%	4,540 $141,000
Q2 2017 Aug 14, 2017	BUY	N/A	5,776	5,776 $158,000

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account